Becton, Dickinson and Company

NYSE:BDX

Medical - Instruments & Supplies

Healthcare
$216.08 +1.67%

+$2.36 today

Market cap
$58.86B
Beta
0.28
P/E (TTM)
35.5
EPS (TTM)
$4.06
Dividend yield
2.60%
52W Low $127.59High $187.35

Volume 1.32M

Average 2.76M

BDX Long-term Debt

Borrowings due after more than one year.

Becton, Dickinson and CompanyNYSE: BDX

Long-term Debt · Q4 FY2026 · quarter ended Sep 2026

Long-term debt falls 23.8% from a year ago

Long-term debt stood at $13.42B at the end of Q4 FY2026, down 23.8% from a year earlier and down 0.7% from the prior quarter. Over 3 fiscal years it compounded at -4.0% a year.

Context

  • Long-term debt amounted to 26.4% of total assets at the end of Q4 FY2026, down 5.4 pp from a year earlier.
  • Long-term debt increased in 1 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether long-term debt keeps falling in the next quarterly balance sheet after a -23.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$13.42B-0.7% QoQ
Last fiscal yearSep 2026
$13.42B-23.8% YoY
Year agoSep 2025
$17.62B-23.8% since
Long-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-23.8%——
1 year-23.8%——
3-year CAGR-4.0%——
5-year CAGR——
10-year CAGR——

Long-term Debt history

USD · from the balance sheet

Latest · FY2026
13.42B USD
Year-over-year change
-23.8%
4-year CAGR
-1.5%

Long-term Debt vs competitors

How BDX compares with its peers on the latest reported figures

  • BDX's Sep 2026 long-term debt of $13.42B is the 3rd highest of the 11 companies compared; the peer median is $2.02B.
  • Its year-over-year change of -23.8% is the 9th highest of 11, against a peer median of -5.6%.
  • Long-term debt amounts to 26.4% of total assets for BDX, versus a peer median of 30.5%.
BDX Competitors Peer median
Long-term Debt for BDX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ABTAbbott LaboratoriesJun 2026$29.6B +128.9%-9.3%27.1%
MDTMedtronic plcJul 2026$25.62B -2.0%+2.5%27.5%
BDXBecton, Dickinson and CompanySep 2026$13.42B -23.8%-4.0%26.4%
BAXBaxter International Inc.Jun 2026$8.62B -9.2%-14.0%43.5%
SOLVSolventum CorporationJun 2026$4.57B -41.5%—32.1%
TFXTeleflex IncorporatedJun 2026$2.72B +51.0%+16.1%40.1%
EMBCEmbecta Corp.Mar 2026$1.32B -12.7%-4.6%127.9%
ICUIICU Medical, Inc.Jun 2026$1.21B -9.4%-6.9%30.5%
MMSIMerit Medical Systems, Inc.Sep 2026$855.11M +16.7%+63.1%—
WSTWest Pharmaceutical Services, Inc.Jun 2026$291.2M +43.7%+13.0%7.1%
BLFSBioLife Solutions, Inc.Mar 2026$0 -100.0%—0.0%
Peer median (excluding BDX) $2.02B-5.6%-1.1%30.5%

Competitors are the stored peer set for BDX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Cash & Equivalents1.16B1.42B1.86B851M725M
Short-term Investments8M8M445M8M8M
Net Receivables2.19B2.53B3.03B2.99B2.77B
Inventory3.22B3.27B3.84B3.89B3.19B
Other Current Assets1.56B1.45B1.29B1.51B1.62B
Total Current Assets8.14B8.68B10.47B9.26B8.32B
Property, Plant & Equipment (Net)6.01B6.56B6.82B7B6.19B
Goodwill24.62B24.52B26.47B33.02B33.62B
Intangible Assets12.31B10.95B10.92B2.99B0
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.85B2.08B2.62B3.06B2.66B
Total Non-current Assets44.79B44.1B46.82B46.07B42.47B
Total Assets52.93B52.78B57.29B55.33B50.79B
Account Payables1.7B1.64B1.9B1.97B0
Short-term Debt2.3B1.26B2.31B1.56B944M
Tax Payables157M139M168M00
Deferred Revenue00000
Other Current Liabilities2.49B2.49B3.33B4.45B0
Total Current Liabilities7.81B6.64B8.96B8.31B944M
Long-term Debt14.27B15.15B18.61B17.62B13.42B
Deferred Tax Liabilities2.67B2.45B2.07B02.2B
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.51B2.33B1.1B4B0
Total Non-current Liabilities19.84B20.34B22.44B21.62B15.62B
Total Liabilities27.65B26.98B31.4B29.94B26.11B
Common Stock365M371M371M371M0
Retained Earnings15.16B15.54B16.14B16.62B0
Accumulated OCI(1.49B)(1.55B)(1.73B)(1.87B)0
Other Stockholders Equity23M24M25M25M50.79B
Minority Interest00000
Total Equity25.28B25.8B25.89B25.39B24.68B
Total Debt16.95B16.82B21.59B19.18B14.37B
Net Debt15.79B15.34B19.73B18.33B13.64B

Becton, Dickinson and Company

NYSE:BDX

Intrinsic Alpha fair value

Locked

Current Price

$216.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.